Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis

Open Access
Publisher Website
Google Scholar
Abstract
Not available. Disclosures: Study sponsored by SUN PHARMA. Copyright SKIN 2018